<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01033526</url>
  </required_header>
  <id_info>
    <org_study_id>11756</org_study_id>
    <secondary_id>EudraCT: 2004-004683-71</secondary_id>
    <nct_id>NCT01033526</nct_id>
  </id_info>
  <brief_title>Symptomatic Treatment of Common Cold Symptoms</brief_title>
  <official_title>A Two-arm, Multicenter, Randomized, Double-blind, Single Dose Placebo-controlled Parallel Groups Study Evaluating Efficacy and Tolerability of 800 mg Acetylsalicylic Acid (AspirinaÂ® C) in Adult Patients With a Common Cold During a Two Hour in Patient Phase; and a Follow-up Period of Five Days of Home Treatment as Required</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A two-arm, multicenter, randomized, double-blind, single dose placebo-controlled parallel
      groups study evaluating efficacy and tolerability of 800 mg Acetylsalicylic Acid (Aspirina C)
      in adult patients with a common cold during a two hour in patient phase; and a follow-up
      period of five days of home treatment as required.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cold Symptoms (patient Wisconsin Upper Respiratory Symptom Survey (WURSS domain 2 score) from baseline</measure>
    <time_frame>2 hours following intake of the first study medication dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Common Cold Profile (sum of WURSS domains 1 182 3)</measure>
    <time_frame>At each of five evenings during the follow-up period (or directly prior to the first intake of rescue medication during the follow-up period)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Global Cold Severity (WURSS domain 1)</measure>
    <time_frame>At each of five evenings during the follow-up period (or directly prior to the first intake of rescue medication during the follow-up period)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cold Symptoms (WURSS domain 2)</measure>
    <time_frame>At each of five evenings during the follow-up period (or directly prior to the first intake of rescue medication during the follow-up period)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cold-specific Functional Impairments (WURSS domain 3)</measure>
    <time_frame>At each of five evenings during the follow-up period (or directly prior to the first intake of rescue medication during the follow-up period)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Global Cold Severity (WURSS domain 4)</measure>
    <time_frame>At each of five evenings during the follow-up period (or directly prior to the first intake of rescue medication during the follow-up period)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event Collection</measure>
    <time_frame>Until end of study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">388</enrollment>
  <condition>Common Cold</condition>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin (Acetylsalicylic acid, BAYE4465)</intervention_name>
    <description>1-2 tablets Acetylsalicylic Acid 400 mg (in combination with Ascorbic Acid 240 mg) as needed every 4-6 hours over a maximum of 5 days</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1-2 tablets matching Placebo as needed every 4-6 hours over a maximum of 5 days</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 65 years

          -  Onset of cold symptoms within 48 hours before screening

          -  Objective symptoms of common cold

          -  Subjective symptoms of common cold

        Exclusion Criteria:

          -  Pregnancy or lactation period

          -  Active peptic ulcer

          -  Hemorrhagic diathesis

          -  History of chronic or recurrent ulcer disease or history of gastro-intestinal bleeding

          -  Hypersensitivity to acetylsalicylic acid, to paracetamol, to any other component of
             the study medication, to anti-inflammatory or antirheumatic drugs, to other allergens
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Borgo Di Terzo</city>
        <state>Bergamo</state>
        <zip>24060</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brembate</city>
        <state>Bergamo</state>
        <zip>24041</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Calusco d'Adda</city>
        <state>Bergamo</state>
        <zip>24033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Capriate San Gervasio</city>
        <state>Bergamo</state>
        <zip>24042</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Caravaggio</city>
        <state>Bergamo</state>
        <zip>24043</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Casazza</city>
        <state>Bergamo</state>
        <zip>24060</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cologno Al Serio</city>
        <state>Bergamo</state>
        <zip>24055</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Covo</city>
        <state>Bergamo</state>
        <zip>24050</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dalmine</city>
        <state>Bergamo</state>
        <zip>24044</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mozzanica</city>
        <state>Bergamo</state>
        <zip>24050</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ponte San Pietro</city>
        <state>Bergamo</state>
        <zip>24036</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seriate</city>
        <state>Bergamo</state>
        <zip>24068</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Verdello</city>
        <state>Bergamo</state>
        <zip>24049</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vertova</city>
        <state>Bergamo</state>
        <zip>24029</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Villa d'Adda</city>
        <state>Bergamo</state>
        <zip>24030</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Angera</city>
        <state>Varese</state>
        <zip>21021</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Carnago</city>
        <state>Varese</state>
        <zip>21040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cavaria</city>
        <state>Varese</state>
        <zip>21044</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Comerio</city>
        <state>Varese</state>
        <zip>21025</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cunardo</city>
        <state>Varese</state>
        <zip>21035</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fagnano Olona</city>
        <state>Varese</state>
        <zip>21054</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Induno Olona</city>
        <state>Varese</state>
        <zip>21056</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sesto Calende</city>
        <state>Varese</state>
        <zip>21018</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Solbiate Olona</city>
        <state>Varese</state>
        <zip>21058</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vedano Olona</city>
        <state>Varese</state>
        <zip>21040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vergiate</city>
        <state>Varese</state>
        <zip>21029</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albano Sant'Alessandro</city>
        <zip>24061</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Varese</city>
        <zip>21100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product</description>
  </link>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2009</study_first_submitted>
  <study_first_submitted_qc>December 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2009</study_first_posted>
  <last_update_submitted>December 15, 2009</last_update_submitted>
  <last_update_submitted_qc>December 15, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Therapeutic Area Head</name_title>
    <organization>Bayer Consumer Care Inc.</organization>
  </responsible_party>
  <keyword>Symptomatic treatment of Common Cold symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Common Cold</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

